Ethyl 1-isopropyl-1H-imidazole-2-carboxylate, 98%, 250mg

methyl 3-{[3-(1H-imidazol-1-yl)propyl]amino}-2-methylpropanoate, 95.0%, 2g

2-Bromoquinoline-6-carbonitrile, 97%, 1g

(S)-tert-Butyl 2-methyl-4-oxopiperidine-1-carboxylate, 95.0%, 10g

3-CHLORO-4,5-DIFLUOROANILINE, 95.0%, 5g

2-Bromo-4-isopropylthiazole, 95.0%, 1g

Acide formique, min 98 %, pour la synthèse, 5 l, emballage plastique.

(4-Chloro-pyrimidin-2-yl)-cyclopropyl-amine, 95.0%, 250mg

2-methyl-5-(3-methyl-5-isoxazolyl)-3-thiophenesulfonyl chloride, 95.0%, 1g

6-Chloro-5-methylpyrimidine-2,4(1H,3H)-dione, 95.0%, 5g

2-(Trifluoromethyl)benzeneboronic acid, 95.0%, 25g

2-([1,1'-BIPHENYL]-2-YLOXY)ETHYL ACRYLATE, 95%, 1g

(2-methylphenoxy)acetic acid, 95.0%, 100g